









Markets
/
Stocks
/
nasdaq-ingn
/

Inogen Inc

INGN

6.110USD

-0.080-1.29%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

110.28MMarket Cap

LossP/E TTM



Inogen Inc

6.110

-0.080-1.29%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Inogen Inc

Currency: USD Updated: 2026-03-27

Key Insights

Inogen Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 56 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inogen Inc's Score

Industry at a Glance

Industry Ranking

56 / 208

Overall Ranking

155 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Inogen Inc Highlights

StrengthsRisks

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Undervalued

The company’s latest PE is -7.24, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 19.74M shares, decreasing 19.07% quarter-over-quarter.

Held by Paul Tudor Jones

Star Investor Paul Tudor Jones holds 151.60K shares of this stock.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

13.000

Target Price

+100.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Inogen Inc is 6.94, ranking 97 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 81.72M, representing a year-over-year increase of 2.05%, while its net profit experienced a year-over-year increase of 26.96%.

Score

Industry at a Glance

Previous score

6.94

Change



Financials

8.96

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.49

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.78

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.35

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Inogen Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Inogen Inc is 8.25, ranking 34 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -7.24, which is -89.90% below the recent high of -0.73 and -17.15% above the recent low of -8.48.

Score

Industry at a Glance

Previous score

8.25

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 56/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Inogen Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 13.00, with a high of 14.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

13.000

Target Price

+110.02%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Inogen Inc

INGN

Medtronic PLC

MDT

Stryker Corp

SYK

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Inogen Inc is 6.80, ranking 60 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 6.64 and the support level at 5.81, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.67

Change

-1.87

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.009

Neutral

RSI(14)

47.160

Neutral

STOCH(KDJ)(9,3,3)

31.631

Sell

ATR(14)

0.242

High Vlolatility

CCI(14)

-47.438

Neutral

Williams %R

83.333

Oversold

TRIX(12,20)

0.167

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

6.308

Sell

MA10

6.258

Sell

MA20

6.261

Sell

MA50

6.066

Buy

MA100

6.467

Sell

MA200

7.050

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Inogen Inc is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 72.70%, representing a quarter-over-quarter decrease of 1.29%. The largest institutional shareholder is The Vanguard, holding a total of 1.42M shares, representing 5.22% of shares outstanding, with 8.89% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP

2.63M

BlackRock Institutional Trust Company, N.A.

1.49M

-1.61%

The Vanguard Group, Inc.

Star Investors

1.43M

-13.50%

Armistice Capital LLC

864.00K

+30.12%

Acadian Asset Management LLC

1.07M

+4.90%

Camber Capital Management LP

975.00K

Columbia Threadneedle Investments (US)

852.73K

-3.22%

Dafna Capital Management, LLC

605.63K

Dimensional Fund Advisors, L.P.

832.53K

+0.04%

Geode Capital Management, L.L.C.

609.29K

-0.97%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Inogen Inc is 5.12, ranking 87 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.73. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.